Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1997 3
1998 2
1999 1
2000 4
2001 4
2002 5
2003 4
2004 4
2005 2
2006 3
2007 2
2008 7
2009 6
2010 4
2011 5
2012 5
2013 10
2014 11
2015 12
2016 16
2017 15
2018 20
2019 15
2020 29
2021 33
2022 26
2023 28
2024 24
2025 19

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

277 results

Results by year

Filters applied: . Clear all
Page 1
The REporting of A Disproportionality Analysis for DrUg Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Explanation and Elaboration.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: raschi e. Drug Saf. 2024 Jun;47(6):585-599. doi: 10.1007/s40264-024-01423-7. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713347 Free PMC article.
The Reporting of a Disproportionality Analysis for Drug Safety Signal Detection Using Individual Case Safety Reports in PharmacoVigilance (READUS-PV): Development and Statement.
Fusaroli M, Salvo F, Begaud B, AlShammari TM, Bate A, Battini V, Brueckner A, Candore G, Carnovale C, Crisafulli S, Cutroneo PM, Dolladille C, Drici MD, Faillie JL, Goldman A, Hauben M, Herdeiro MT, Mahaux O, Manlik K, Montastruc F, Noguchi Y, Norén GN, Noseda R, Onakpoya IJ, Pariente A, Poluzzi E, Salem M, Sartori D, Trinh NTH, Tuccori M, van Hunsel F, van Puijenbroek E, Raschi E, Khouri C. Fusaroli M, et al. Among authors: raschi e. Drug Saf. 2024 Jun;47(6):575-584. doi: 10.1007/s40264-024-01421-9. Epub 2024 May 7. Drug Saf. 2024. PMID: 38713346 Free PMC article.
Fluoroquinolones and Aortic Disease.
Gatti M, Raschi E, De Ponti F. Gatti M, et al. Among authors: raschi e. JAMA Intern Med. 2021 Jun 1;181(6):881. doi: 10.1001/jamainternmed.2020.9226. JAMA Intern Med. 2021. PMID: 33646264 No abstract available.
The challenges of lupus anticoagulants.
Chighizola CB, Raschi E, Banzato A, Borghi MO, Pengo V, Meroni PL. Chighizola CB, et al. Among authors: raschi e. Expert Rev Hematol. 2016;9(4):389-400. doi: 10.1586/17474086.2016.1140034. Epub 2016 Feb 3. Expert Rev Hematol. 2016. PMID: 26789237 Review.
277 results